NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS
申请人:Jansen R&D Ireland
公开号:US20150111868A1
公开(公告)日:2015-04-23
The present invention is concerned with novel 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles having formula (I)
stereoisomeric forms thereof, and the pharmaceutically acceptable addition salts, and the solvates thereof,
wherein R
4
, R
5
, Z and Het have the meaning defined in the claims. The compounds according to the present invention are useful as inhibitors on the replication of the respiratory syncytial virus (RSV). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.
本发明涉及具有式(I)的杂环取代的新颖1,3-二氢-2H-苯并咪唑-2-酮衍生物及其立体异构体形式,以及药学上可接受的加盐和溶剂化物,其中R4、R5、Z和Het在权利要求中定义的含义。根据本发明的化合物在抑制呼吸道合胞病毒(RSV)复制方面具有用途。本发明进一步涉及制备这种新颖化合物、包含这些化合物的组合物,以及用于治疗呼吸道合胞病毒感染的化合物。